Diabetes Explains Higher Heart Death Rates For Recipients Of Angioplasty

October 06, 1997

DALLAS, Oct. 7. -- A long-term study shows that individuals whose coronary arteries are obstructed and who are treated with angioplasty have more heart-related deaths than those who undergo bypass surgery.

The higher rate, however, is due to deaths of people with diabetes, according to a study in today's American Heart Association journal Circulation.

"Death rates are higher in persons with diabetes since they have more coronary heart disease and more heart attacks," says Bernard Chaitman, M.D., professor of medicine and chief of cardiology at St. Louis University School of Medicine.

The findings are results of the Bypass Angioplasty Revascularization Investigation (BARI) Randomized Trial, which is based at the University of Pittsburgh and sponsored by the National Heart, Lung and Blood Institute (NHLBI).

Angioplasty is a nonsurgical procedure that uses a balloon catheter to dilate or widen an obstructed part of a coronary artery. Coronary bypass surgery is an open-heart operation in which arteries or veins are taken from another part of the body and surgically attached to the coronary arteries. The attached vessels circumvent the blocked coronary artery.

After a five year follow-up study of 1,829 patients, the heart disease death rate in patients treated for angioplasty was 8 percent compared to 4.9 percent of those having had bypass. On the other hand, no significant differences in death rates were found among nondiabetic patients within the study.

"The long-term outcome of patients with multivessel (more than one vessel involved) coronary disease is not compromised among nondiabetic patients when angioplasty is chosen as the initial treatment strategy," says Chaitman.

"However, more research is needed to explore new advances in angioplasty such as stents and strategies of early aggressive intervention in diabetics."

Advances in medical therapy of diabetes may also improve the heart death rates among diabetic patients, the report says.

A cautious approach should be pursued toward recommending new interventions for people with diabetes with advanced heart disease until these approaches are tested and understood, adds Chaitman.

Contact: Dr. Chaitman can be reached at (314-577-8890)
-end-


American Heart Association

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.